Fulcrum bags global rights for GSK’s failed trial drug Losmapimod
Fulcrum plans to initiate a Phase 2b clinical trial in mid-2019 on patients with FSHD…
Lilly & Avidity ink new licensing & research collaboration agreement
The collaboration specifically focuses on the development, discovery and commercialization for potential new drugs. Under…
Alembic Pharma receives FDA approval for Teriflunomide tablets
The company now possesses over 91 ANDA approvals, approximately 79 final approvals & 12 tentative…
Roche Pharma introduces Hemophilia A treatment drug in India
The new drug would be sold under the brand name Hemlibra in the country It…
FDA prohibits Coloplast, Boston Scientific from selling surgical mesh
The companies have a total of 10 days to submit their plans for pulling out…
MediciNova plans to move ahead with phase-3 trial of MN-166 in ALS
The trial would be funded entirely by MediciNova The result of a successful pivotal trial…
Dr. Reddy’s Laboratories acquires 42 ANDAs portfolio in the U.S.
The portfolio in question includes over 30 generic injectable products. The latest acquisition expands Dr.…
Catalent Inc to acquire Paragon Bioservices in a $1.2 billion deal
The acquisition would be helping Catalent in expanding its capabilities of developing costly & specialized…
Cerner and naviHealth to add a new offering to BPCI Advanced program
Cerner and naviHealth have reportedly expanded their relationship in a bid to introduce new offerings…